Sriwijaya Journal of Internal Medicine (SJIM) — e-ISSN 2988-3237, published by Phlox Institute. By submitting to SJIM, authors agree to comply with these Author Guidelines and with the journal's Publication Ethics and Malpractice Statement.

1. Scope

SJIM publishes work spanning general internal medicine and its subspecialties — cardiovascular medicine, pulmonology, gastroenterology and hepatology, endocrinology and diabetes, nephrology, haematology and medical oncology, infectious and tropical diseases, rheumatology, geriatric and psychosomatic medicine, critical and hospital medicine — together with related basic, translational, and public-health research (see Focus & Scope). Submissions must fall within this scope and make a clear contribution to knowledge or practice.

2. Article Types & Abstract Structure

There is no fixed limit on manuscript length or on the number of tables and figures; authors should nonetheless aim for clarity and avoid unnecessary repetition. The abstract is preferably ≤ 250 words; its structure depends on the article type:

3. Language and General Format

• Clear, grammatically correct academic English (British or American spelling, applied consistently throughout).
• Editable text file (Microsoft Word, .docx), 12-point font, double-spaced, with continuous line and page numbering.
• SI units throughout; all abbreviations defined at first mention; drugs referred to by their international non-proprietary (generic) names.

4. Manuscript Structure

Title Page (separate file)

Uploaded as a separate file, containing: the full title; each author's full name and institutional affiliation; the corresponding author's postal address, e-mail, and telephone; each author's ORCID iD; a running title; word count; and the numbers of tables and figures. Information that could identify the authors must appear only on this page.

Blinded Main Manuscript

Because SJIM operates double-blind peer review, the main manuscript file must not contain author names, affiliations, acknowledgements, funding details, or any other information that could reveal the authors' identity. Self-citations should be phrased neutrally.

Main Text, Tables & Figures

Original Articles follow IMRAD; the Methods must describe the design, setting, participants, ethical approval, and statistical analysis in sufficient detail for replication. Case Reports follow the CARE structure; Systematic Reviews follow PRISMA and include a flow diagram. Tables and figures are placed within the main text near first mention, numbered in order of citation, each with a concise legend (above tables, below figures). Figures: line art ≥ 600 dpi, photographs/clinical images ≥ 300 dpi. For any image from which a patient could be identified, signed consent for publication is required and identifying features should be masked unless specifically consented otherwise.

References

References follow the Vancouver (ICMJE) style: numbered consecutively in the order of first citation, with in-text numbers as superscript Arabic numerals; journal titles abbreviated per the NLM Catalog; include the DOI where available; list the first three authors followed by “et al.” when there are more than three. At least 80% of references should be primary research (original) articles, most published within the last ten years, preferably in reputable internationally indexed journals. Authors are responsible for the accuracy and verifiability of every reference; the fabrication of references, or the use of unverified references generated by artificial-intelligence tools, is a serious breach of publication ethics and will result in rejection.

5. Ethics and Required Declarations

All submissions must comply with the journal's Publication Ethics statement (aligned with COPE, ICMJE, and WAME). The following are required, as applicable:

• Ethical approval: Research involving human participants must be approved by an appropriate ethics committee/IRB, comply with the Declaration of Helsinki, and state the approval number in the Methods; written informed consent must have been obtained.
• Patient consent for identifiable material: For any identifiable patient information or image, a signed SJIM Patient Consent for Publication form must be uploaded at submission. Particular care is taken with sensitive diagnoses (HIV, viral hepatitis, tuberculosis, mental-health comorbidity).
• Animal research: Compliance with applicable guidelines, reporting per the ARRIVE guidelines, and the ethics approval number.
• Clinical trial registration: Prospective registration in a recognised public registry; the registration number must appear in the abstract.
• Authorship & contributions: the four ICMJE criteria; a CRediT statement; a completed SJIM Author Declaration, Authorship & Conflict-of-Interest Statement.
• AI use, data availability, reporting guidelines (CONSORT/STROBE/STARD/PRISMA/CARE), and originality/plagiarism: as set out in the ethics statement.

6. Files Required at Submission

• Cover letter.
• Title page (with all identifying information).
• Blinded main manuscript (abstract, references, table/figure legends).
• Main manuscript with tables and figures embedded near first mention.
• Completed SJIM Author Declaration, Authorship & Conflict-of-Interest Statement.
• Signed SJIM Patient Consent for Publication form (where any identifiable patient material is included).
• Copy of the ethics committee / IRB approval (for studies involving humans or animals).

7–9. Submission, Peer Review & Copyright

All manuscripts are submitted through the journal's online submission system or to sjim.editor@gmail.com. There is no submission fee. Submissions are first assessed for scope, completeness, and compliance, then undergo double-blind review by at least two independent expert reviewers, with the editorial office acting as intermediary to preserve anonymity. Editorial decisions are based solely on academic merit, validity, ethical compliance, and peer review, and are entirely independent of the authors' ability to pay any charge. Authors retain copyright; on acceptance, authors grant SJIM the right of first publication, with the article licensed under CC BY-NC-SA 4.0. An Article Processing Charge applies only after acceptance (see the Publication Fee page).